MASTERINVEST Kapitalanlage GmbH Purchases New Stake in Cigna Group $CI

MASTERINVEST Kapitalanlage GmbH acquired a new position in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 8,109 shares of the health services provider’s stock, valued at approximately $2,235,000.

Several other large investors have also recently bought and sold shares of the business. Assetmark Inc. lifted its stake in shares of Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after purchasing an additional 5,963 shares during the period. Mystic Asset Management Inc. purchased a new stake in Cigna Group during the second quarter worth about $2,808,000. KBC Group NV grew its position in Cigna Group by 6.4% during the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after buying an additional 22,978 shares during the period. Sanctuary Advisors LLC acquired a new position in Cigna Group during the second quarter worth about $11,043,000. Finally, HighTower Advisors LLC increased its holdings in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after buying an additional 283,897 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CI. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Barclays boosted their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Stock Down 1.3%

Shares of NYSE CI opened at $277.21 on Friday. The firm’s 50-day moving average is $283.53 and its two-hundred day moving average is $281.41. The company has a market capitalization of $73.25 billion, a PE ratio of 11.47, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the company posted $7.20 EPS. The company’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 23,012 shares of company stock valued at $6,386,550 in the last three months. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.